Biodesix, Inc. (BDSX) vs Burning Rock Biotech Limited Sponsored ADR (BNR)

Biodesix, Inc. and Burning Rock Biotech Limited Sponsored ADR are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $260.7M against $137.1M — 1.9× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 34.5% against −0.14%. Burning Rock Biotech Limited Sponsored ADR has the higher net margin (−13.5% vs −27.0%) and the lower return on invested capital (−50.7% vs −49.6%). Across the 18 metrics below, Burning Rock Biotech Limited Sponsored ADR leads on 11 and Biodesix, Inc. on 7.

Valuation

Metric BDSX BNR Diagnostics & Research median
P/E n/m n/m 35.56
P/S 2.37 18.73 4.37
P/B 26.64 18.81 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 2.53 17.89 5.51
Earnings yield (13.40%) (4.09%) (1.89%)
Free cash flow yield (8.37%) (1.06%) (0.15%)

Profitability

Metric BDSX BNR Diagnostics & Research median
Gross margin 82.50% 74.50% 50.89%
Operating margin (20.02%) (12.95%) (8.57%)
Net margin (26.97%) (13.51%) (6.37%)
Free cash flow margin (19.82%) (3.00%) 0.00%
Return on equity (540.01%) (13.08%) (2.92%)
Return on assets (30.33%) (8.81%) (6.71%)
Return on invested capital (49.60%) (50.66%) 0.00%

Growth

Metric BDSX BNR Diagnostics & Research median
Revenue growth (TTM) 34.46% (0.14%) 7.69%
EPS growth (last fiscal year) 29.24% 84.16% 25.92%
Revenue growth, 5-year CAGR 14.20% 3.21% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX BNR Diagnostics & Research median
Debt to equity 5.12 0.00 0.11
Current ratio 2.85 3.05 2.02
Net debt to EBITDA (1.36) 14.48 0.70

Dividend

Metric BDSX BNR Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BDSX BNR Diagnostics & Research median
Market cap 260.72m 137.12m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack